| Srl | Item |
| 1 |
ID:
172077
|
|
|
|
|
| Summary/Abstract |
Global public health has struggled to provide timely warning of influenza pandemics. In this study, we review the signal pattern of local media reporting associated with the 1918 type A/H1N1 influenza pandemic and subsequent return of the A/H1N1 virus in 1977 and 1978 in Philadelphia. Open source local media reports are a critical source of warning intelligence for influenza pandemics. Documentation and analysis of pandemic influenza signal patterns is essential to capture lessons in effective warning intelligence for health security.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2 |
ID:
097012
|
|
|
|
|
| Publication |
2010.
|
| Summary/Abstract |
Intellectual property (IP) is a reward and incentive market-driven mechanism for fostering innovation and creativity. The underlying, but disputed, assumption to this logic is that without IP, the wheel of innovation and inventiveness may grind to a halt or spin at a lower and unhelpful pace. This conventional justification of IP enjoys, perhaps, greater empirical credibility with the patent regime than with other regimes. Despite the inconclusive role of patents as a stimulant for research and development (R&D), special exception is given to patent's positive impact on innovation and inventiveness in the pharmaceutical sector. This article focuses on that sector and links the palpable disconnect between the current pharmaceutical R&D agenda and global public health crises, especially access to drugs for needy populations, to a flaw in the reward and incentive theory of the patent system. It proposes a creative access model to the benefits of pharmaceutical research by pointing in the direction of a global treaty to empower and institutionalize private-public partnerships in health care provisions. Such a regime would restore balance in the global IP system that presently undermines the public-regarding considerations in IP jurisprudence.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
ID:
124593
|
|
|
|
|
| Publication |
2013.
|
| Summary/Abstract |
The Fukushima nuclear disaster is far from over and remains a global health concern. While evacuations, sheltering, reducing intake of contaminated food, and other measures reduced radiation exposures, both the immediate and longer-term public health responses to the disaster leave major room for improvement. Commercially and institutionally, vested interests have undermined public health and safety.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|